Cargando…
Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis
Advanced extremity melanoma and sarcoma present a significant therapeutic challenge, requiring multimodality therapy to treat or even palliate disease. These aggressive tumours are relatively chemo-resistant, therefore new treatment approaches are urgently required. We have previously reported on th...
Autores principales: | Wilkinson, Michelle J., Smith, Henry G., McEntee, Gráinne, Kyula-Currie, Joan, Pencavel, Tim D., Mansfield, David C., Khan, Aadil A., Roulstone, Victoria, Hayes, Andrew J., Harrington, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348387/ https://www.ncbi.nlm.nih.gov/pubmed/27783991 http://dx.doi.org/10.18632/oncotarget.12820 |
Ejemplares similares
-
Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma
por: Wilkinson, Michelle J., et al.
Publicado: (2016) -
Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling
por: McEntee, Gráinne, et al.
Publicado: (2016) -
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer
por: Mansfield, D C, et al.
Publicado: (2016) -
Radiation lays down covering fire for viral shock troops
por: Kyula, Joan N., et al.
Publicado: (2013) -
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
por: Thomas, Suzanne, et al.
Publicado: (2019)